Three-year probabilities of PFS in patients with acute leukemia after intermediate-intensity dCBT. (A) Three-year PFS according to pretransplant MRD status in the 52 patients with acute leukemia in complete remission. (B) Three-year PFS in 40 AML patients transplanted in CR according to their ELN 2010 genetic risk classification at diagnosis.